End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 73.41M 100M |
---|---|---|---|---|---|
Net income 2024 * | -52M -71.14M | Net income 2025 * | -54M -73.87M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.42
x | P/E ratio 2025 * |
-1.39
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.94% |
Latest transcript on Ventrus Biosciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 20-03-29 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | 46 | 11-07 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 59 | 17-12-13 |
Gina Consylman
BRD | Director/Board Member | 52 | 20-10-19 |
William Ringo
CHM | Chairman | 78 | 14-06-30 |
1st Jan change | Capi. | |
---|---|---|
+7.22% | 72.81B | |
+14.09% | 9.13B | |
-11.75% | 5.13B | |
+59.61% | 4.99B | |
+2.62% | 3.9B | |
-17.54% | 2.48B | |
+21.35% | 2.42B | |
-27.82% | 2.32B | |
+25.13% | 2.17B |